Study S002596

Effect of Glucagon-like Peptide -1 Receptor Agonist on Liver Tissue and Plasma Lipids in MASLD

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06982378
Acronym: OMICS in MASLD
Study type: OBSERVATIONAL
Status: WITHDRAWN
Enrollment: 0
Start: 2026-07-01
Primary completion: 2026-07-09
Lead sponsor: Medical College of Wisconsin
Conditions: NAFLD; Diabetes; Obesity
Interventions: DRUG:GLP-1 receptor agonist
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Changes in lipidomics profile on use of GLP-1 RA [1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.